New combination therapy of registered re-purposed drugs dramatically shortens anti-Wolbachia therapy for lymphatic filariasis and onchocerciasis from weeks to days
Researchers from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting Wolbachia, a bacterial symbiont that the filarial parasites need to live, the team has discovered a drug synergy that enables effective treatment […]
